The same month, Teva announced the ¥40 billion purchase of a majority stake in Japanese generic drug company Taiyo Pharmaceutical Industry, a move to secure a Japan-local production facility. Teva completed the $934 million acquisition in July 2011.
The same period saw Teva acquire a significant stake in Japanese generic drug manufacturer Taiyo Pharmaceutical Industry, aiming to set up a domestic production facility. Teva finalized this deal in July 2011 at a cost of $934 million.